CTOs on the Move


 
Apptix is the premier provider of hosted business communication, collaboration, and IT solutions to business of all sizes from SOHO to Fortune 500 with particular expertise supporting legal, financial, healthcare, and telecom firms.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.apptix.com
  • 13461 Sunrise Valley Dr Ste 300
    Herndon, VA USA 20171
  • Phone: 866.428.0130

Executives

Name Title Contact Details

Similar Companies

AwareX

AwareX enables you to engage your customers in a mobile-first world with a platform that provides a personalized customer experience for all.

Security First Credit Union

Security First Credit Union is the largest “homegrown” credit union in the Rio Grande Valley. We pride ourselves on being “from the valley, for the valley.”

TruSight

TruSight Solutions is the best practices third-party assessment service created by leading industry participants for the collective benefit of all financial institutions, their suppliers, partners, and other third parties.

Librato

Librato is a leading provider of software for maximizing the utilization of hardware and software assets in clouds and data centers, while maintaining the desired application Quality of Service.

Kapost

Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.